High-Density Lipoprotein as a Therapeutic Target: Treatment Strategies.
Artículo
en Inglés
| IMSEAR
| ID: sea-168239
ABSTRACT
Coronary artery disease (CAD) is one of the most important causes of morbidity and mortality worldwide despite considerable therapeutic advances that control the risk factors. Numerous clinical trials have shown an inverse association between high density lipoprotein cholesterol levels and the risk of coronary artery disease. So, high density lipoprotein has become a new therapeutic target after low density lipoprotein in the management of risk factors of coronary artery disease. In this review, we explore existing and future treatment strategies along with their benefits and failures which will guide our management strategy. HDL raising therapies showed very promising results in many clinical trials but larger clinical trials are ongoing.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Tipo de estudio:
Factores de riesgo
Idioma:
Inglés
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS